KOD Kodiak Pharma Net earnings per share growth forecast for next year

Kodiak Sciences Inc. (KOD) - corporate logo

The synergy of an academic R&D approach and the flawless operation of cleanrooms ensures the stable production of drugs. The shift in the consensus earnings per share forecast visualizes this potential, with the value fixed at 5.20. An option program retains top scientists, while a high reputation as an innovator among ophthalmologists confirms the status of Kodiak Sciences Inc. (KOD) as a leader in retinal disease therapy.

KOD: Kodiak Sciences Inc Projected earnings per share growth rate for next year 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Kodiak Sciences Inc (KOD)

- price and consensus price forecast:
Basic company analysis:Kodiak Sciences Inc.
Finished products of Kodiak Sciences

This indicator reflects the market discounting of future earnings through the lens of the business's margin resilience to tight monetary policy. By analyzing the expected EPS dynamics for the next period, investors assess the ability of Kodiak Sciences Inc. (KOD) to generate profit, which is supported by the steady utilization of R&D laboratories and strict adherence to production schedules for experimental ophthalmological drugs in cleanrooms.

Competitor analysis for Kodiak Sciences Inc.

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Expected net earnings per share growth next year aldeyra.com ALDX|Earnings growth forecast for next year KALA|IRD - Expected net earnings per share growth next year|Earnings growth forecast for next year OKYO (OKYO Pharma Limited)|ADVM - Expected earnings per share growth for next year|OTLK: Expected earnings per share growth for next year|CLSD (Clearside) - Projected earnings per share growth rate for next year|NBY: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)